Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is any type of epithelial lung cancer different from small-cell lung carcinoma (SCLC). NSCLC accounts for about 80-85% of all lung cancers. The most common sub-types of NSCLC are squamous cell carcinoma, large-cell carcinoma, and adenocarcinoma. These subtypes, which start from different types of lung cells, are grouped together as NSCLC because their treatment and prognoses (outlook) are often similar.

Showing the single result

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
PD-1
Monoclonal Antibody
Libtayo®
50 mg/mL
5 mg
tba
tba
569,00 
view product
Max:
Min: 10
Step: 1

Not looking for Non-Small Cell Lung Cancer?

Search our therapeutic molecules product database